508 results on '"Claesson-Welsh, L."'
Search Results
2. Claudin5 protects the peripheral endothelial barrier in an organ and vessel-type-specific manner
3. Tyrosine-protein kinase Yes controls endothelial junctional plasticity and barrier integrity by regulating VE-cadherin phosphorylation and endocytosis
4. Structure and Function of Vascular Endothelial Growth Factor Receptor-1 and -2
5. Claudin5 protects the peripheral endothelial barrier in an organ and vessel type-specific manner
6. Embryonic stem cell models in vascular biology
7. The mechanisms of VEGF-A-induced recruitment of pro-angiogenic neutrophils: 1.73
8. VEGFA and tumour angiogenesis
9. Introduction to symposium on vascular biology, metabolism and cancer
10. Pre-determined macromolecular leakage sites with dynamic properties establish endothelial intra-vessel heterogeneity
11. Angiogenesis in cancer: 151
12. 51Shear stress, notch and VE-cadherin: the molecular mechanism of vascular fusion
13. Novel high affinity affibody for radionuclide imaging of VEGFR2 in glioma vasculature : proof-of-principle in murine model
14. Highly sensitive and specific protein detection via combined capillary isoelectric focusing and proximity ligation
15. Developmentally regulated expression of two novel platelet-derived growth factor alpha-receptor transcript in human teratocarcinoma cells
16. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF
17. p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling
18. 1108 Histidine-rich Glycoprotein Regulates Macrophage Differentiation
19. Signal Transduction by Vascular Endothelial Growth Factor Receptors
20. Angiogenesis in Synergy with Fibroblast Growth Factor by Distinct Regulation of the Gene and Protein. Expression Profile in Endothelial Cells.
21. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins
22. Signal transduction by vascular endothelial growth factor receptors.
23. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways.
24. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.
25. VEGF-receptor signal transduction
26. [Islet of Langerhans transplantation in type I diabetes. Regulation of neovascularization in the transplant is a key question]
27. Endostatin action and intracellular signaling: beta-catenin as a potential target?
28. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin
29. Shb is a ubiquitously expressed Src homology 2 protein
30. Role of heparan sulfate domain organization in endostatin inhibition ofendothelial cell function.
31. Heparin amplifies platelet-derived growth factor (PDGF)- BB-induced PDGFalpha -receptor but not PDGF beta -receptor tyrosine phosphorylation inheparan sulfate-deficient cells. Effects on signal transduction andbiological responses.
32. Endostatin regulates endothelial cell adhesion and cytoskeletalorganization.
33. Angiogeneshämmare sannolikt komplement vid cancerbehandlingar
34. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers.
35. FGF and VEGF function in angiogenesis: signalling pathways, biologicalresponses and therapeutic inhibition.
36. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focaladhesion kinase.
37. A novel anti-angiogenic form of antithrombin with retained proteinasebinding ability and heparin affinity.
38. Phosphoinositide 3 kinase is critical for survival, mitogenesis and migration, but not for differentiation of endothelial cells
39. VEGF receptor signal transduction.
40. Signal transduction by VEGF receptor-1 wild type and mutant proteins.
41. Antiangiogenic effects of latent antithrombin through perturbedcell-matrix interactions and apoptosis of endothelial cells.
42. Endostatins derived from collagens XV and XVIII differ in structural andbinding properties, tissue distribution and anti-angiogenic activity.
43. Selectively desulfated heparin inhibits fibroblast growth factor-inducedmitogenicity and angiogenesis.
44. Multiple effects of heparin on VEGF binding and transduction of biological responses
45. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis
46. Dual effects of heparin on VEGF binding to VEGF receptor-1 and transduction of biological responses
47. FGFR-1 mediated endothelial cell proliferation is depend-ent on the SH27SH3 domain-containing adaptor protein Crk
48. Signal transduction by fibroblast growth factor receptors.
49. Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation.
50. Structure and function of vascular endothelial growth factor receptor-1 and -2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.